The (+D+CAD) group reported to take antidepressants (24%), beta-blockers (71%), angiotensinconverting-enzyme-(ACE)-inhibitors (81%), and Angiotensin II receptor type-(AT1)-antagonists (14%). Here, ACE is linked to coronary artery disorder.